HomeInsightsEPS

Glaxosmithkline Pharmaceuticals Ltd EPS

Glaxosmithkline Pharmaceuticals Ltd EPS

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Dec 27, 2024)

stocks purchased

1.3 K

Stocks Traded

(Dec 27, 2024)

Last Updated on: Dec 27, 2024

Image

Glaxosmithkline Pharmaceuticals Ltd

NSE: GLAXO

EPS

₹ 47.33

Last updated on: Dec 27, 2024

Key Highlights

  • The Earning per Share of Glaxosmithkline Pharmaceuticals Ltd is ₹ 47.33 as of 27 Dec 24 .
  • The earning per share of Glaxosmithkline Pharmaceuticals Ltd changed from ₹ 7.04 to ₹ 14.67 over 10 quarters. This represents a CAGR of 34.14% .

Historical Earning per Share of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Glaxosmithkline Pharmaceuticals Ltd

Market Cap

38,472 Cr

EPS

47.3

P/E Ratio (TTM) *

48.0

P/B Ratio (TTM) *

23.0

Day’s High *

2294.95

Day’s Low

2245.0

DTE *

0.0

ROE *

47.9

52 Week High

3087.95

52 Week Low

1764.85

ROCE *

64.4

Market Price of Glaxosmithkline Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glaxosmithkline Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
27 Dec 20242271.05
26 Dec 20242241.8
24 Dec 20242265.1
23 Dec 20242282.85
20 Dec 20242284.5
19 Dec 20242325.25
18 Dec 20242334.95
17 Dec 20242264.65
16 Dec 20242278.95
13 Dec 20242254.45

SWOT Analysis Of Glaxosmithkline Pharmaceuticals Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Glaxosmithkline Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Glaxosmithkline Pharmaceuticals Ltd

Market Value

38,473

Asset Value

2,149

16.9 X

Value addition

* All values are in Rupees

Competitive Comparison of EPS

Historical Market Cap of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Glaxosmithkline Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Glaxosmithkline Pharmaceuticals Ltd News Hub

News

GSK Pharma gains as Q2 PAT rises 15% YoY to Rs 249 cr

Profit before exceptional item and tax was at Rs 338.70 crore in the September 2024 quarte...

Read more

30 Oct 2024 10:39

News

Board of GlaxoSmithKline Pharmaceuticals recommends Special Interim Dividend

GlaxoSmithKline Pharmaceuticals announced that the Board of Directors of the Company at it...

Read more

29 Oct 2024 16:10

News

GlaxoSmithKline Pharmaceuticals to declare Quarterly Result

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

25 Oct 2024 10:38

News

GSK Pharma Q1 PAT climbs 39% YoY to Rs 182 crore

Revenue from operations grew by 9.89% year on year (YoY) to Rs 811 crore during the quarte...

Read more

03 Aug 2024 12:25

News

GlaxoSmithKline Pharmaceuticals to convene board meeting

GlaxoSmithKline Pharmaceuticals will hold a meeting of the Board of Directors of the Compa...

Read more

18 Jul 2024 10:38

News

Glaxosmithkline Pharmaceuticals announces change in senior management

Glaxosmithkline Pharmaceuticals announced that Dr. Shalini Menon has been appointed as Exe...

Read more

05 Jul 2024 13:26

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

May 2024

Transcript

Mar 2023

Transcript

Aug 2021

PPT

Feb 2020

PPT

FAQs for EPS of Glaxosmithkline Pharmaceuticals Ltd

What is the EPS of Glaxosmithkline Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Glaxosmithkline Pharmaceuticals Ltd is 47.33. An EPS is the amount of net income attributed to each share of a common stock.

How is Glaxosmithkline Pharmaceuticals Ltd EPS calculated?

The EPS of Glaxosmithkline Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Glaxosmithkline Pharmaceuticals Ltd report its EPS?

Glaxosmithkline Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Glaxosmithkline Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Glaxosmithkline Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Glaxosmithkline Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Glaxosmithkline Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions